Fair global drug pricing-Reference-Cited by-同舟云学术

Fair global drug pricing

Published:2018-09-28 Issue:6 Volume:18 Page:581-583
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Campbell Jonathan D.¹,Kaló Zoltán²³^ORCID

Affiliation:

1. Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Denver, Colorado, USA

2. Department of Health Policy and Economics, Institute of Economics, Faculty of Social Sciences, Eötvös Loránd University (ELTE)

3. Syreon Research Institute

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2018.1524296

Reference13 articles.

1. The U.S. Department of Health & Human Services. American Patients First 2018. [cited 2018 June 15]. Available from: https://www.hhs.gov/sites/default/files/AmericanPatientsFirst.pdf.

2. An Incomplete Prescription

3. Value-Based Pricing and Patient Access for Specialty Drugs

4. Health Care Spending in the United States and Other High-Income Countries

5. Value‐Based Differential Pricing: Efficient Prices for Drugs in a Global Context

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interface policies bridging outpatient and hospital sectors in Europe: can cross-sectorial collaboration in reimbursement and procurement improve access to affordable medicines?;Expert Review of Pharmacoeconomics & Outcomes Research;2023-07-26

2. Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications;Expert Review of Pharmacoeconomics & Outcomes Research;2021-03-11

3. Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab;Applied Health Economics and Health Policy;2019-11-07

4. Price competition and reimbursement of biosimilar granulocyte-colony stimulating factor in Hungary;Expert Review of Pharmacoeconomics & Outcomes Research;2019-02-26

5. Observational health research in Europe: understanding the General Data Protection Regulation and underlying debate;European Journal of Cancer;2018-11